Email us :
Finding Efficiency in Clinical Research

PharmaTech Outlook Recognizes Waife & Associates, Inc. among Top 10 Clinical Data Management Solution Providers 2016

FREMONT, CA-(Pharma Tech Outlook- Jun 15, 2016) – Waife & Associates, today announced that it has been recognized by Pharma Tech Outlook for Top 10 Clinical Data Management Solution Providers 2016.

Pharma Tech Outlook features its ‘Top 10 Clinical Data Management Solution Providers’ list annually in recognition of the top tech organizations helping business around the world. A variety of subjective and objective criteria were used for choosing the winners. Waife & Associates specializes in biopharma clinical research, process consulting in clinical research, information technology implementation (EDC, CTMS, AES, EDMS, etc.), and change management.

“It is a great honor to announce Waife & Associates, Inc. as one among the Top 10 Clinical Data Management Solution Providers 2016,” said Stacey Smith, Managing Editor of Pharma Tech Outlook “Waife & Associates has been making great strides in the clinical data management arena and demonstrates its prowess in helping clinical research organizations and pharmaceutical industries to make better decisions.”  

About Pharma Tech Outlook

Published from Fremont, California, Pharma Tech Outlook is a print magazine that covers most important and latest developments in pharmaceutical industries. A distinguished panel comprising of top IT decision makers, CIOs and CTOs from the pharma and life sciences industry, as well as the Pharma Tech Outlook editorial board finalized the ‘Top 10 Clinical Data Management Solution Providers 2016’ in the U.S. and shortlisted the best vendors and consultants. For more info:

About Waife & Associates, Inc.

Waife & Associates, Inc. was established in 1993 to help clinical research companies build competitive advantage through process improvement and technology adoption. Headquartered in MA, U.S., it applies senior domain expertise to provide pragmatic solutions to common operations challenges. For more info, visit

Sorry, the comment form is closed at this time.